Literature DB >> 21638239

Cholestatic liver diseases from child to adult: the diversity of MDR3 disease.

R Kubitz1, J Bode, A Erhardt, D Graf, G Kircheis, I Müller-Stöver, R Reinehr, S Reuter, J Richter, A Sagir, M Schmitt, M Donner.   

Abstract

The phospholipidfloppase MDR3 (gene symbol: ABCB4) is expressed in the canalicular membrane of hepatocytes and mediates the biliary excretion of phosphatidylcholine, which is required for the formation of mixed micelles in bile. Several mutations of ABCB4 have been identified, which cause cholestatic liver diseases of varying severity including progressive familial intrahepatic cholestasis type 3 (PFIC-3), intrahepatic cholestasis of pregnancy (ICP) and the low phospholipid associated cholelithiasis syndrome (LPAC). Here, we report on four new (S1076N; L 23Hfs16X; c.286 + 1G > A; Q 1181E) and one known (S27G) MDR3 mutations in eight patients of three families. The patients presented with a wide spectrum of liver diseases. The clinical presentation and decisive laboratory findings or the association to a trend-setting family history led to the identification of the genetic background in these patients. Even the same mutation may be associated with varying disease progression. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21638239     DOI: 10.1055/s-0031-1273427

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  6 in total

1.  Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice.

Authors:  Shi-Ying Cai; Albert Mennone; Carol J Soroka; James L Boyer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-30       Impact factor: 4.052

2.  A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.

Authors:  Marianne Kluth; Jan Stindt; Carola Dröge; Doris Linnemann; Ralf Kubitz; Lutz Schmitt
Journal:  J Biol Chem       Date:  2014-12-22       Impact factor: 5.157

3.  Case report: progressive familial intrahepatic cholestasis type 3 with compound heterozygous ABCB4 variants diagnosed 15 years after liver transplantation.

Authors:  Mariam Goubran; Ayodeji Aderibigbe; Emmanuel Jacquemin; Catherine Guettier; Safwat Girgis; Vincent Bain; Andrew L Mason
Journal:  BMC Med Genet       Date:  2020-11-30       Impact factor: 2.103

4.  Hepatobiliary anomalies associated with ABCB4/MDR3 deficiency in adults: a pictorial essay.

Authors:  Julie Benzimra; Sarah Derhy; Olivier Rosmorduc; Yves Menu; Raoul Poupon; Lionel Arrivé
Journal:  Insights Imaging       Date:  2013-04-17

5.  Correlation between mutation of MDR3 gene exon 6 and parenteral nutrition-associated cholestasis of preterm infants.

Authors:  Xiu Fang Yang; Guo Sheng Liu; Bing Yi
Journal:  Exp Ther Med       Date:  2014-09-19       Impact factor: 2.447

6.  Phenotypic spectrum and diagnostic pitfalls of ABCB4 deficiency depending on age of onset.

Authors:  Stephanie Barbara Schatz; Christoph Jüngst; Verena Keitel-Anselmo; Ralf Kubitz; Christina Becker; Patrick Gerner; Eva-Doreen Pfister; Imeke Goldschmidt; Norman Junge; Daniel Wenning; Stephan Gehring; Stefan Arens; Dirk Bretschneider; Dirk Grothues; Guido Engelmann; Frank Lammert; Ulrich Baumann
Journal:  Hepatol Commun       Date:  2018-03-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.